Mentholated cigarettes and smoking-related cancers revisited: An ecologic examination

Regulatory Toxicology and Pharmacology

Volumn 63, Issue 1, 2012, Pages 132-139

  Kabat, Geoffrey C ^a   Shivappa, Nitin ^b   Hébert, James R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Ecologic study; Esophageal cancer; Laryngeal cancer; Lung cancer; Mentholated cigarettes; Oropharyngeal cancer; Prevalence; Sales

Indexed keywords

MENTHOL;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; ECOLOGY; ESOPHAGUS CANCER; FEMALE; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OROPHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING RELATED CANCER; SQUAMOUS CELL CARCINOMA;

AFRICAN AMERICANS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MENTHOL; OROPHARYNGEAL NEOPLASMS; RESPIRATORY TRACT NEOPLASMS; SMOKING;

NICOTIANA TABACUM;

EID: 84859481987     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.03.002     Document Type: Article

References (67)

1. Azzi C., Zhang J., Purdon C.H., Chapman J.M., Nitcheva D., Hebert J.R., Smith E.W. Permeation and reservoir formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (BAP) across porcine esophageal tissue in the presence of ethanol and menthol. Carcinogenesis 2006, 27:137-145.
2. Bartsch H., Pignatelli B., Calmels S., Ohshima H. Inhibition of nitrosation. Basic Life Sci. 1993, 61:27-44.
3. Blot W.J., Cohen S.S., Aldrich M., McLaughlin J.K., Hargreaves M.K., Signorello L.B. Lung cancer risk among smokers of menthol cigarettes. JNCI 2011, 103:810-816.
4. Brooks D.R., Palmer J.R., Strom B.L., Rosenberg L. Menthol cigarettes and risk of lung cancer. Am. J. Epidemiol. 2003, 158:609-616.
5. Brown L.M., Hoover R., Silverman D., Baris D., Hayes R., Swanson G.M., Schoenberg J., Greenberg R., Liff J., Schwartz A., Dosemeci M., Pottern L., Fraumeni J.F. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am. J. Epidemiol. 2001, 153:114-122.
6. Brown L.M., Hoover R.N., Greenberg R.S., Schoenberg J.B., Schwartz A.G., Swanson G.M., Liff J.M., Silverman D.T., Hayes R.B., Pottern L.M. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use?. J. Natl Cancer Inst. 1994, 86:1340-1345.
7. Carpenter C.L., Jarvik M.E., Morgenstern H., McCarthy W.J., London S.J. Mentholated cigarette smoking and lung-cancer risk. Ann. Epidemiol. 1999, 9:114-120.
8. Castellsague X., Munoz N., De Stefani E., Victora C.G., Castelletto R., Rolon P.A. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int. J. Cancer 2000, 88:658-664.
9. Castellsague X., Munoz N., De Stefani E., Victora C.G., Castelletto R., Rolon P.A., Quintana M.J. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer 1999, 82:657-664.
10. Chatila W.M., Wynkoop W.A., Vance G., Criner G.J. Smoking patterns in African Americans and whites with advanced COPD. Chest 2004, 125:15-21.
11. Chu K.C., Miller B.A., Springfield S.A. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J. Natl Med. Assoc. 2007, 99:1092-1104.
12. Cropsey K.L., Weaver M.F., Eldridge G.D., Villalobos G.C., Best A.M., Stitzer M.L. Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob. Res. 2009, 11:690-697.
13. Cubbin C., Soobader M.-J., LeClere F.B. The intersection of gender and race/ethnicity in smoking behaviors among menthol and non-menthol smokers in the United States. Addiction 2010, 105(Suppl 1):32-38.
14. Dubowitz T., Heron M., Basurto-Davila R., Bird C.E., Lurie N., Escarce J.J. Racial/ethnic differences in US health behaviors: a decomposition analysis. Am. J. Health Behav. 2011, 35:290-304.
15. Etzel C.J., Kachroo S., Liu M., D'Amelio A., Dong Q., Cote M.L., Wenzlaff A.S., Hong W.K., Greisinger A.J., Schwartz A.G., Spitz M.R. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev. Res. 2008, 1:255-265.
16. Federated Electronic Research, Review, Extraction, and Tabulation Tool. Vol. 2011 2011, FERRETT, US Census Bureau, Washington, DC.
17. Finkenauer R., Pomerleau C.S., Snedecor S.M., Pomerleau O.F. Race differences in factors relating to smoking initiation. Addict. Behav. 2009, 34:1056-1059.
18. Friedman G.D., Sadler M., Tekawa I.S., Sidney S. Mentholated cigarettes and non-lung smoking related cancers in California, USA. Epidemiol. Commun. Health 1998, 52:202.
19. Gadgeel S.M., Kalemkerian G.P. Racial differences in lung cancer. Cancer Metastasis Rev. 2003, 22:39-46.
20. Gandhi K.K., Foulds J., Steinberg M.B., Lu S.E., Williams J.M. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int. J. Clin. Pract. 2009, 63:360-367.
21. Ghadirian P. Familial history of esophageal cancer. Cancer 1985, 56:2112-2116.
22. Giovino G.A., Sidney S., Gfroerer J.C., O'Malley P.M., Allen J.A., Richter P.A., Cummings K.M. Epidemiology of menthol cigarette use. Nicotine Tob. Res. 2004, 6(Suppl 1):S67-S81.
23. Harford T.C. Drinking patterns among black and nonblack adolescents: results of a national survey. Ann. N. Y. Acad. Sci. 1986, 472:130-141.
24. Hebert J.R. Invited commentary: menthol cigarettes and risk of lung cancer. Am. J. Epidemiol. 2003, 158:617-620.
25. Hebert J.R., Adams S.A., Daguise V.G., Hurley D., Smith E.W., Purdon C., Lawson A., Mitas M., Reed C.E. Esophageal cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J. South Carolina Med. Assoc. 2006, 102:201-209.
26. Hebert J.R., Kabat G.C. Menthol cigarette smoking and esophageal cancer. Am. J. Public Health 1988, 78:986-987.
27. Hebert J.R., Kabat G.C. Menthol cigarette smoking and Oesophageal cancer: results of a case-control study. Int. J. Epidemiol. 1989, 18:37-44.
28. SEER Cancer Statistics Review, 1975-2008 2011, National Cancer Institute, Bethesda, MD. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feue, K.A. Cronin, B.K. Edwards (Eds.).
29. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2008, 58:71-96.
30. Kabat G.C. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States. Lung Cancer 1996, 15:1-20.
31. Kabat G.C., Hebert J.R. Use of mentholated cigarettes and lung cancer risk. Cancer Res. 1991, 51:6510-6513.
32. Kabat G.C., Hebert J.R. Use of mentholated cigarettes and oropharyngeal cancer. Epidemiology 1994, 5:183-188.
33. Kabat G.C., Morabia A., Wynder E. Comparison of smoking habits of blacks and whites in a case-control study. Am. J. Public Health 1991, 81:1483-1486.
34. Kant A.K., Graubard B.I., Kumanyika S.K. Trends in black-white differentials in dietary intakes of US adults, 1971-2002. Am. J. Prev. Med. 2007, 32:264-272.
35. Lawrence D., Rose A., Fagan P., Moolchan E.T., Gibson J.T., Backinger C.L. National patterns and correlates of mentholated cigarette use in the United States. Addiction 2010, 105(Suppl 1):13-31.
36. Lee P.N. Systematic review of the epidemiological evidence comparing lung cancer risk in smokers of mentholated and unmentholated cigarettes. BMC Pulm. Med. 2011, 11:18.
37. Reports Maxwell. Historical Trends in the Tobacco Industry, 1925-1967 1977, Maxwell Associates, New York.
38. Reports Maxwell Historical Trends in the Tobacco Industry: Fifty-two Year Summary 1977, Maxwell Associates, Richmond, VA.
39. Maxwell Reports: Year-end Sales Estimates for the Cigarette Industry, 1968-1986. Maxwell Associates, New York, 1986.
40. Maxwell Reports: Year-end and Fourth Quarter 2008 Sales Estimates for the Cigarette Industry, 2008. Maxwell Associates, New York, 2009.
41. Maxwell Reports: Year-end and Fourth Quarter Sales Estimates for the Cigarette Industry for 1973, 1977, 1982, 1988, 1992, 1997, 2002 and 2007 Vol. 2011. Maxwell Associates, New York, 2011.
42. Menthol Report Overview - Tobacco Products Scientific Advisory Committee's Report and Recommendations on the Impact of the Use of Menthol in Cigarettes on the Public Health. FDA, Washington, DC, 2011.
43. Morgan G.D., Backinger C.L., Leischow S.J. The future of tobacco-control research. Cancer Epidemiol. Biomark. Prev. 2007, 16:1077-1080.
44. Murphy-Hoefer R., Hyland A., Higbee C. Perceived effectiveness of tobacco countermarketing advertisements among young adults. Am. J. Health Behav. 2008, 32:725-734.
45. Murray R.P., Connett J.E., Skeans M.A., Tashkin D.P. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob. Res. 2007, 9:101-107.
46. Muscat J.E., Chen G., Knipe A., Stellman S.D., Lazarus P., Richie J.P. Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol. Biomark. Prev. 2009, 18:35-41.
47. Cancer Statistics Review 1973-88 1991, 91-2789. National Cancer Institute, National Cancer Institute, Bethesda. L. Ries (Ed.).
48. Okuyemi K.S., Faseru B., Sanderson Cox L., Bronars C.A., Ahluwalia J.S. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction 2007, 102:1979-1986.
49. Pratt M.M., John K., MacLean A.B., Afework S., Phillips D.H., Poirier M.C. Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. Int. J. Environ. Health Res. 2011, 8:2675-2691.
50. Preston-Martin S., Correa P. Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv. 1989, 8:459-473.
51. Richie J.P., Carmella S.G., Muscat J.E., Scott D.G., Akerkar S.A., Hecht S.S. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol. Biomark. Prev. 1997, 6:783-790.
52. Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Edwards B.K. Cancer Statistics Review 1975-2002 2005, National Cancer Institute, Bethesda, MD.
53. Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., Feuer E.J., Edwards B.K. SEER Cancer Statistics Review, 1975-2000 2001, National Cancer Institute, Bethesda, MD.
54. Ries, L.A.G., Harkins, D., Krapcho, M., Mariotto, A., Miller, B.A., Feuer, E.J., Clegg, L., Eisner, M.P., Horner, M.J., Howlander, N., Hayat, M., Hankey, B.F., Edwards, B.K., SEER Cancer Statistics Review, 1975-2003. National Cancer Institute, based on November 2005 SEER data submission, posted to the SEER web site, 2006, Bethesda, MD, 2006. http://seer.cancer.gov.
55. Rock V.J., Davis S.P., Thorne S.L., Asman K.J., Caraballo R.S. Menthol cigarette use among racial and ethnic groups in the United States, 2004-2008. Nicotine Tob. Res. 2010, 12(Suppl 2):S117-S124.
56. Cigarette Survey Reports 1986, Roper Organization, The Roper Organization, New York.
57. Rothman K.J., Greenland S. Modern Epidemiology 1998, Lippincott - Raven, Philadelphia.
58. Sidney S., Tekawa I.S., Friedman G.D., Sadler M.C., Tashkin D.P. Mentholated cigarette use and lung cancer. Arch Int Med. 1995, 155:727-732.
59. Sloan F.A., Grossman D.S. Alcohol consumption in early adulthood and schooling completed and labor market outcomes at midlife by race and gender. Am. J. Public Health 2011, 101:2093-2101.
60. Squier C.A., Mantz M.J., Wertz P.W. Effect of menthol on the penetration of tobacco carcinogens and nicotine across porcine oral mucosa ex vivo. Nicotine Tob. Res. 2010, 12:763-767.
61. Stellman S.D., Chen Y., Muscat J.E., Djordjevic I.V., Richie J.P., Lazarus P., Thompson S., Altorki N., Berwick M., Citron M.L., Harlap S., Kaur T.B., Neugut A.I., Olson S., Travaline J.M., Witorsch P., Zhang Z.F. Lung cancer risk in white and black Americans. Ann. Epidemiol. 2003, 13:294-302.
62. Tollefson L. The use of epidemiology, scientific data, and regulatory authority to determine risk factors in cancer of some organs of the digestive system. 2. Esophageal cancer. [Review] [109 refs]. Regul. Toxicol. Pharmacol. 1985, 5:255-275.
63. United States Cancer Statistics: 1999-2005 Incidence and Mortality Web-based Report. U. S. Department of Health and Human Services, Centers for Disease Control and Prevention 2009, US Cancer Statistics Working Group, US DHHS/CDC/NIH-NCI, Atlanta (GA).
64. Victora C.G., Munoz N., Day N.E., Barcelos L.B., Peccin D.A., Braga N.M. Hot beverages and oesophageal cancer in southern Brazil: a case-control study. Int. J. Cancer 1987, 39:710-716.
65. Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J. Clin. 2004, 54:78-93.
66. Zaridze D., Blettner M., Trapeznikou N., Kuvshinou J., Matiakin E., Poljakov B. Survey of a population with a high incidence of oral and oesophageal cancer. Int. J. Cancer 1985, 36:153-158.
67. Zaridze D.G., Huvshinov J.P., Matiakin E., Polakov B.I., Boyle P., Blettner M. Chemoprevention of oral and esophageal cancer in Uzbekistan, Union of Soviet Socialist Republics. J. Natl. Cancer Inst. Monogr. 1985, 69:259-262.